相关实验视频
Updated: Jan 12, 2026
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.2K
坎普斯特可以减轻过敏性喘时的呼吸道炎症:来自小鼠模型和分子对接分析的见解
Hafsa Abid1, Aisha Mobashar2,3, Arham Shabbir4
1Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
Naunyn-Schmiedeberg's archives of pharmacology
|November 7, 2025
概括
坎普斯特醇是一种植物类固醇,在过敏性喘的小鼠模型中有效降低了炎症和肺. 这表明坎普斯特作为一种潜在的替代疗法来治疗喘症状.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 喘是一种复杂,异质的呼吸系统疾病,具有显著的发病率和死亡率.
- 现有的治疗方法可能有局限性,需要寻找新的治疗药物.
- 坎普斯特醇是一种植物固醇,具有已知的抗炎和抗氧化特性.
研究的目的:
- 在过敏性喘的小鼠模型中研究坎佩斯特醇的治疗潜力.
- 为了评估坎佩斯特对炎症标志物,肺病理和的作用.
- 通过in silico分析探索坎佩斯特醇作用的分子机制.
主要方法:
- 在BALB/c小鼠中使用卵蛋白敏感化和鼻腔挑战诱导过敏喘.
- 治疗小鼠时使用不同剂量的坎佩斯特醇或甲基prednisolone.
- 评估了关键的炎症标志物 (IL-4,IL-5),水素 (AQP-1,AQP-5),白细胞计数和肺部组织病理学.
- 在基分子对接中对JAK2,TNF-α和NF-κB进行了对接.
主要成果:
- 坎普斯特治疗显著降低了全白细胞和分白细胞的数量以及肺部炎症细胞的透.
- 促炎性细胞因子IL-4和IL-5的表达显著下降.
- 水素AQP-1和AQP-5的表达显著增加,与减少的肺湿/干比相关.
- 在分析显示,坎佩斯特醇对关键炎症点具有强烈的结合亲和力.
结论:
- 坎普斯特在过敏性喘模型中显示出显著的抗炎和抗作用.
- 通过降低IL-4/IL-5的调节和提高AQP-1/AQP-5的调节,可以调节治疗效益.
- 坎普斯特醇显示出作为一种潜在的替代治疗药物来治疗过敏性喘的潜力.
更多相关视频
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:26Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
1.7K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.7K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K